Sarah Wakeman
Biographic Data
| ID | 7450499 |
|---|---|
| NAME | Sarah Wakeman |
| GIVEN NAMES | Sarah |
| FAMILY NAME | Wakeman |
| SIGNATURE | WAKEMAN S |
| AFFILIATIONS | Harvard Medical School |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder
BACKGROUND: Recent prevalence estimates of cannabis use among individuals receiving medication treatment for OUD (MOUD) are lacking, and no study has characterized cannabis route of administration (cROA) in this population. These knowledge gaps are relevant because cannabis' effects and health outcomes vary by cROA and the availability and perceptions of cROA (e.g., vaping devices) are changing. METHODS: The Vaping In Buprenorphine-treated patien…
Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York
The results of this cross-sectional study suggest the need for progress in engaging patients in SUD treatment and improvement in the low performance of SUD care and limited variation in MMC plans in New York, New York. Improvement in the overall performance of SUD treatment in Medicaid potentially depends on general program improvements, not moving recipients among plans
Changes in characteristics of drug overdose death trends during the Covid-19 pandemic
Literature in Brief
No prominent works on this page.
Literature in Brief
Changes in characteristics of drug overdose death trends during the Covid-19 pandemic
Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder
BACKGROUND: Recent prevalence estimates of cannabis use among individuals receiving medication treatment for OUD (MOUD) are lacking, and no study has characterized cannabis route of administration (cROA) in this population. These knowledge gaps are relevant because cannabis' effects and health outcomes vary by cROA and the availability and perceptions of cROA (e.g., vaping devices) are changing. METHODS: The Vaping In Buprenorphine-treated patien…
Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York
The results of this cross-sectional study suggest the need for progress in engaging patients in SUD treatment and improvement in the low performance of SUD care and limited variation in MMC plans in New York, New York. Improvement in the overall performance of SUD treatment in Medicaid potentially depends on general program improvements, not moving recipients among plans
Medicine (4 works) · Psychiatry (3 works) · Demography (2 works) · Demography (2 works) · Drug (2 works) · Gerontology (2 works) · Internal Medicine (2 works) · Opioid (2 works) · Opioid use disorder (2 works) · Opioid Use Disorder Treatment (2 works)